1184 related articles for article (PubMed ID: 15031734)
41. Deconvolution of the cellular oxidative stress response with organelle-specific Peptide conjugates.
Mahon KP; Potocky TB; Blair D; Roy MD; Stewart KM; Chiles TC; Kelley SO
Chem Biol; 2007 Aug; 14(8):923-30. PubMed ID: 17719491
[TBL] [Abstract][Full Text] [Related]
42. Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy.
Cente M; Filipcik P; Pevalova M; Novak M
Eur J Neurosci; 2006 Aug; 24(4):1085-90. PubMed ID: 16930434
[TBL] [Abstract][Full Text] [Related]
43. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease.
Pashkow FJ; Watumull DG; Campbell CL
Am J Cardiol; 2008 May; 101(10A):58D-68D. PubMed ID: 18474276
[TBL] [Abstract][Full Text] [Related]
44. Metal attenuating therapies in neurodegenerative disease.
Mot AI; Wedd AG; Sinclair L; Brown DR; Collins SJ; Brazier MW
Expert Rev Neurother; 2011 Dec; 11(12):1717-45. PubMed ID: 22091597
[TBL] [Abstract][Full Text] [Related]
45. Reactive oxygen species and the neurodegenerative disorders.
Knight JA
Ann Clin Lab Sci; 1997; 27(1):11-25. PubMed ID: 8997453
[TBL] [Abstract][Full Text] [Related]
46. Can malondialdehyde be used as a biological marker of progression in neurodegenerative disease?
Dib M; Garrel C; Favier A; Robin V; Desnuelle C
J Neurol; 2002 Apr; 249(4):367-74. PubMed ID: 11967639
[TBL] [Abstract][Full Text] [Related]
47. Metal ions and oxidative protein modification in neurological disease.
Sayre LM; Moreira PI; Smith MA; Perry G
Ann Ist Super Sanita; 2005; 41(2):143-64. PubMed ID: 16244388
[TBL] [Abstract][Full Text] [Related]
48. Determination of Parameters of Oxidative Stress in vitro Models of Neurodegenerative Diseases-A Review.
Feitosa CM; da Silva Oliveira GL; do Nascimento Cavalcante A; Morais Chaves SK; Rai M
Curr Clin Pharmacol; 2018; 13(2):100-109. PubMed ID: 29493463
[TBL] [Abstract][Full Text] [Related]
49. Apomorphine, a dopamine receptor agonist with remarkable antioxidant and cytoprotective properties.
Gassen M; Gross A; Youdim MB
Adv Neurol; 1999; 80():297-302. PubMed ID: 10410734
[No Abstract] [Full Text] [Related]
50. Role of transition metals ion and reactive oxygen species in biological oxidation in cattle (part 1).
Kleczkowski M; Kluciński W; Sikora J; Kasztelan R; Zdanowicz M
Pol J Vet Sci; 2002; 5(4):263-8. PubMed ID: 12512561
[TBL] [Abstract][Full Text] [Related]
51. [The role of the oxygen-binding properties of the blood in maintaining pro-oxidant-antioxidant equilibrium in the body].
Zinchuk VV; Borisiuk MV
Usp Fiziol Nauk; 1999; 30(3):38-48. PubMed ID: 10512010
[TBL] [Abstract][Full Text] [Related]
52. Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope?
Carvalho AN; Firuzi O; Gama MJ; Horssen JV; Saso L
Curr Drug Targets; 2017 Mar; 18(6):705-718. PubMed ID: 27033198
[TBL] [Abstract][Full Text] [Related]
53. Roles of dioxins and heavy metals in cancer and neurological diseases using ROS-mediated mechanisms.
Matés JM; Segura JA; Alonso FJ; Márquez J
Free Radic Biol Med; 2010 Nov; 49(9):1328-41. PubMed ID: 20696237
[TBL] [Abstract][Full Text] [Related]
54. Crosstalk between mitochondrial dysfunction, oxidative stress, and age related neurodegenerative disease: Etiologies and therapeutic strategies.
Elfawy HA; Das B
Life Sci; 2019 Feb; 218():165-184. PubMed ID: 30578866
[TBL] [Abstract][Full Text] [Related]
55. Chronic inflammatory disorders and their redox control: from molecular mechanisms to therapeutic opportunities.
Chiurchiù V; Maccarrone M
Antioxid Redox Signal; 2011 Nov; 15(9):2605-41. PubMed ID: 21391902
[TBL] [Abstract][Full Text] [Related]
56. Iron toxicity in neurodegeneration.
Núñez MT; Urrutia P; Mena N; Aguirre P; Tapia V; Salazar J
Biometals; 2012 Aug; 25(4):761-76. PubMed ID: 22318507
[TBL] [Abstract][Full Text] [Related]
57. Apoptosis and oxidative stress in neurodegenerative diseases.
Radi E; Formichi P; Battisti C; Federico A
J Alzheimers Dis; 2014; 42 Suppl 3():S125-52. PubMed ID: 25056458
[TBL] [Abstract][Full Text] [Related]
58. Cerebral atherosclerosis causes neurodegenerative diseases.
Rafael H
Med Sci Monit; 2010 Jan; 16(1):LE1-2. PubMed ID: 20037498
[No Abstract] [Full Text] [Related]
59. Metals in our minds: therapeutic implications for neurodegenerative disorders.
Doraiswamy PM; Finefrock AE
Lancet Neurol; 2004 Jul; 3(7):431-4. PubMed ID: 15207800
[TBL] [Abstract][Full Text] [Related]
60. Oxidative imbalance in different neurodegenerative diseases with memory impairment.
Gironi M; Bianchi A; Russo A; Alberoni M; Ceresa L; Angelini A; Cursano C; Mariani E; Nemni R; Kullmann C; Farina E; Martinelli Boneschi F
Neurodegener Dis; 2011; 8(3):129-37. PubMed ID: 20838029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
